GRAS Notices
-
GRN No. 725
Inactivated Bacillus coagulans GBI-30, 6086
Intended Use: | For use as an ingredient in non-exempt term infant formula at levels up to 2 x 108 CFU inactivated cells per 100 mL of infant formula as consumed. |
---|---|
Basis: | Scientific procedures |
Notifier: | Ganeden Biotech, Inc. |
Notifier Address: | 5800 Landerbrook Drive, Suite 300 Mayfield Heights, OH, 44124 |
GRAS Notice (releasable information): | GRN 725 (in PDF) (5.2 MB) |
Date of closure: | Feb 12, 2018 |
FDA's Letter: | FDA has no questions (in PDF) (52 kB) |
-